基本信息
views: 123
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Dr. John Thompson has devoted his career to developing better ways to treat kidney cancer and melanoma. His clinical research efforts focus on novel therapies such as cancer immunotherapy using activated lymphocytes, cytokines, and antibodies. Dr. Thompson leads the Phase 1 Clinical Trials Program at Fred Hutch. Researchers in this program work with biotechnology and pharmaceutical firms to develop novel therapies for patients with cancer. Dr. Thompson’s goal is to speed the translation of experimental approaches into clinically useful therapies to improve the lives of patients.
Research Interests
Papers共 82 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Alberto Chiappori,John Thompson,Fredericus Eskens, Jean-Philippe Spano,Toshihiko Doi,Omid Hamid,Adi Diab,Naiyer Rizvi,Siwen Hu-Lieskovan,Willeke Ros, Jacob Thomas,Alison Forgie,
Load More
Author Statistics
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn